As understanding of the human microbiome improves, novel therapeutic targets to improve human health with microbial therapeutics will continue to expand. We outline key considerations of balancing risks and benefits, optimising access, returning key results to research participants, and potential conflicts of interest.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996990 | PMC |
http://dx.doi.org/10.1080/20502877.2017.1387386 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!